Search this website. You can use fund codes to locate specific funds

Global Emerging Markets: ESG Materiality, Q2 2019

Welcome to the inaugural edition of the Hermes Global Emerging Markets’ ESG Materiality commentary – a quarterly publication that will demonstrate our engagement activity with portfolio companies and showcase holdings that are creating positive impact aligned to the Sustainable Development Goals. In addition, we will explore an environmental, social and governance theme and its implications for the asset class.

Over the past decade, we have sought to act as responsible investors in the emerging-market equity space by focusing on companies that can tackle sustainability challenges as they arise. We recognise that developing markets have a long way to go in this respect, but as responsible investors, we can contribute to their evolution over time.

ESG Materiality, Q2 2019

• Engaging with The Foschini Group on ESG issues
• Will the new Mercosur-EU trade deal raise the risks of deforestation?
• Delta Electronics: creating positive impact

More Insights

Monthly Fund Commentary, April 2020
Please read on for more information and a summary of performance, activity and our investment outlook, from our Portfolio Managers.
Weekly Credit Insight
In an atmosphere of uncertainty, dispersion between high and low-quality credit has risen.
Building back better: why climate action is key to a resilient recovery
Why stimulus measures should be combined with efforts to tackle climate change
Fiorino: in this pandemic, asset quality is key to banks' health
In this launch issue of our Fiorino blog, we assess how banks are preparing for corporate defaults resulting from lockdowns across economies worldwide.
Gemologist: can we adapt to a new climate normal?
Climate change will test our ability to avoid mortal danger more than ever before. Humanity’s ability to adapt, something we have excelled at, must again come to the fore.
Portfolio triage: Market Risk Insights, Q2 2020
Just as overstretched hospitals triage critical patients, investors must triage the risks to their portfolios and prioritise them.